Madrigal Pharmaceuticals Inc (MDGL)

83.24 -2.93  -3.40% NASDAQ Oct 18, 16:00 83.26 +0.02  +0.02% After-Hours: 20:00 USD

Madrigal Pharmaceuticals Enterprise Value:

1.107B for Oct. 15, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Enterprise Value Chart

Export Data
Save Image
Print Image

Historical Enterprise Value Data

View and export this data going back to 2007. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Oct. 15, 2021 1.107B
Oct. 14, 2021 1.063B
Oct. 13, 2021 1.025B
Oct. 12, 2021 1.041B
Oct. 11, 2021 1.026B
Oct. 8, 2021 1.017B
Oct. 7, 2021 1.019B
Oct. 6, 2021 976.76M
Oct. 5, 2021 981.25M
Oct. 4, 2021 984.73M
Oct. 1, 2021 1.012B
Sept. 30, 2021 1.001B
Sept. 29, 2021 1.005B
Sept. 28, 2021 1.031B
Sept. 27, 2021 1.082B
Sept. 24, 2021 1.085B
Sept. 23, 2021 1.086B
Sept. 22, 2021 981.74M
Sept. 21, 2021 978.26M
Sept. 20, 2021 977.93M
Sept. 17, 2021 1.033B
Sept. 16, 2021 1.007B
Sept. 15, 2021 993.86M
Sept. 14, 2021 990.54M
Sept. 13, 2021 1.004B
   
Sept. 10, 2021 1.006B
Sept. 9, 2021 1.006B
Sept. 8, 2021 976.76M
Sept. 7, 2021 999.01M
Sept. 3, 2021 1.017B
Sept. 2, 2021 1.070B
Sept. 1, 2021 1.065B
Aug. 31, 2021 1.050B
Aug. 30, 2021 1.055B
Aug. 27, 2021 1.054B
Aug. 26, 2021 1.032B
Aug. 25, 2021 1.045B
Aug. 24, 2021 1.042B
Aug. 23, 2021 1.069B
Aug. 20, 2021 1.013B
Aug. 19, 2021 983.90M
Aug. 18, 2021 1.017B
Aug. 17, 2021 1.042B
Aug. 16, 2021 1.052B
Aug. 13, 2021 1.085B
Aug. 12, 2021 1.094B
Aug. 11, 2021 1.082B
Aug. 10, 2021 1.091B
Aug. 9, 2021 1.126B
Aug. 6, 2021 1.186B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Benchmarks

Akero Therapeutics Inc 513.92M
908 Devices Inc 759.56M
Twist Bioscience Corp 5.043B

Enterprise Value Range, Past 5 Years

Minimum 119.39M Jun 20 2017
Maximum 4.619B Jun 13 2018
Average 1.223B

Enterprise Value Related Metrics

Net Income (Quarterly) -61.65M
Total Expenses (Quarterly) 61.74M
EPS Diluted (Quarterly) -3.72
Earnings Yield -17.55%
Normalized Earnings Yield -42.04

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.